December 4 - 8, 2022
Marriott Marquis San Diego,
Live In-Person Event: December 4 - 8, 2022
THE #1 ANTIBODY ENGINEERING CONFERENCE FOR ACCELERATING NEXT GENERATION ANTIBODIES TO COMMERCIAL SUCCESS
The latest science and research on antibody engineering, design and selection diving into critical topics including immuno-oncology, cellular engagers, miniproteins, the Fc region, cancer therapy, novel bi-specifics/multispecifics and much more!
Login Details
All login details were sent on Monday 28 November from Disha.Koshal@informa.com. If you have not received your login, please check your spam. If you do not receive anything by EOB Tuesday 29 November, please contact Disha.Koshal@informa.com.
Registered recently? You will receive your login information 48 hours after registering.
2022 Keynote Speakers
Celebrating 33 Years of Bringing The Community Together to Discuss Time-Critical Antibody Engineering Updates and Best Practices
Brand New Session Themes for 2022:
- How to Develop an Antibody-based Drug from Discovery to IND?
- Adaptive Immune Receptor Repertoire Data Processing, Annotation and Interpretation
- Antibody Engineering, Libraries and Selection
- Novel Targets for Antibody Therapeutics
- Engineering the Fc Region to Improve Therapeutic Effects
- Functional Screening Integrated Into Initial Antibody Discovery
- Miniprotein Engineering
- Strategies to Engineer Cell-based Immunotherapies
Brand New Session Themes for 2022:
- Advances with Antibody-based Cellular Engagers
- Remodeling the Tumor Microenvironment for Cancer Therapy
- Novel Bispecifics, Multi-specifics and Therapeutic Combinations
- Advancing Antibody Therapeutics in Immuno-oncology
- Targeted Conjugates - Antibodies and Novel Platforms
- Antibodies in Infectious Diseases
- Progress and Challenges of Computational Approaches for Antibody Discovery and Engineering
3 Unmissable Add-On Options
Extend your learning even further with 3 vital add-on options designed to embed your knowledge prior to the main conference.
Options include:
- Pre-Conference Half-Day Workshop A (PM): How to Develop an Antibody-based Drug from Discovery to IND?
- Pre-Conference Half-Day Workshop B (PM): Adaptive Immune Receptor Repertoire Data Processing, Annotation and Interpretation
- Pre-Conference Full-Day Training Course: Introduction to Antibody Engineering
Get the latest news.
As it happens
Get the latest event updates
About the Antibody Society
The Antibody Society is an international, non-profit representing individuals and organizations involved in antibody-related research and development. The Society has a variety of initiatives and working groups focused on improving the antibody field.
We are:
- Creating opportunities for education and networking;
- Monitoring and reporting advances in the commercial pipeline for antibody and CAR-T therapeutics;
- Creating standards for characterizing antibody and T-cell receptor repertoires, and engaging this field;
- Engaging government and international agencies on matters concerning the antibody community;
Please join us!
Put Yourself Infront Of Key Antibody Decision-Makers!
Whether you're increasing your company profile, launching a new product or focusing on new business development opportunities, collaborate with us to identify custom solutions to help you reach your goals.
Contact Kristen Schott: KSchott@informaconnectls.com
